Breaking the barrier: MMP2/HAase dual-triggered liposomal nanoplatform for enhanced tumor penetration and immunogenic cell death
- 25 October 2026
- journal article
- Published by Elsevier in International Immunopharmacology
- Vol. 191 (Pt 1) , 117601
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Nanomedicine for colorectal cancer therapy by remodeling the immune microenvironmentJournal of Controlled Release, 2026
- Pullulan-stabilized gliadin nanocomplexes loaded with astragaloside IV: Fabrication, characterization and treatment of ulcerative colitisCarbohydrate Polymers, 2026
- Biomimetic cell membrane-mediated nanodelivery platform based on natural products: Emerging strategies for cancer combination therapyBiomaterials, 2025
- Update 2025: Management of Non‑Small-Cell Lung CancerLung, 2025
- Simplified Lipid Nanoparticles for Tissue‐ And Cell‐Targeted mRNA Delivery Facilitate Precision Tumor Therapy in a Lung Metastasis Mouse ModelAdvanced Materials, 2024
- Inducing Immunogenic Cancer Cell Death through Oxygen‐Economized Photodynamic Therapy with Nitric Oxide‐Releasing PhotosensitizersAngewandte Chemie International Edition, 2024
- Marsdenia tenacissima extract induces endoplasmic reticulum stress-associated immunogenic cell death in non-small cell lung cancer cells through targeting AXLJournal of Ethnopharmacology, 2023
- Chlorin e6-induced photodynamic effect facilitates immunogenic cell death of lung cancer as a result of oxidative endoplasmic reticulum stress and DNA damageInternational Immunopharmacology, 2023
- Changes in the expression of membrane type-matrix metalloproteinases genes (MMP14, MMP15, MMP16, MMP24) during treatment and their potential impact on the survival of patients with non-small cell lung cancer (NSCLC)Biomedicine & Pharmacotherapy, 2022
- Docetaxel-loaded D-α-tocopheryl polyethylene glycol-1000 succinate liposomes improve lung cancer chemotherapy and reverse multidrug resistanceDrug Delivery and Translational Research, 2020